Robert Hofmeister
Net worth: - $ as of 30/07/2026
Net worth: - $ as of 30/07/2026
Robert Hofmeister currently works at Molkerei Hainichen Freiberg GmbH & Co. KG, as Co-Managing Director.
Dr. Hofmeister also formerly worked at Alaunos Therapeutics, Inc., as Independent Director from 2023 to 2025, EMD Serono Research & Development Institute, Inc., as Global Head-Translational Immunotherapy from 2012 to 2015, and TCR2 Therapeutics, Inc., as Senior Vice President-Research & Development.
Dr. Hofmeister received his doctorate degree from the University of Regensburg.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/04/2025 | 0 ( -.--% ) | - $ | 30/07/2026 |
| Companies | Position | Start |
|---|---|---|
Molkerei Hainichen Freiberg GmbH & Co. KG
Molkerei Hainichen Freiberg GmbH & Co. KG Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dairy and cheese products | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Director/Board Member | 14/04/2025 |
| TCR2 THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 28/02/2022 |
EMD Serono Research & Development Institute, Inc. | Corporate Officer/Principal | 31/12/2014 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
University of Regensburg
University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono Research & Development Institute, Inc. | |
Molkerei Hainichen Freiberg GmbH & Co. KG
Molkerei Hainichen Freiberg GmbH & Co. KG Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dairy and cheese products | Consumer Non-Durables |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Select your edition
All financial news and data tailored to specific country editions